We are live on ! Find out more
OTLK icon

Outlook Therapeutics
OTLK

54 hedge funds and large institutions have $4.32M invested in Outlook Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

294% more call options, than puts

Call options by funds: $351K | Put options by funds: $89K

8.62% less ownership

Funds ownership: 17.8% → 9.18% (-8.6%)

18% less funds holding

Funds holding: 66 → 54 (-12)

52% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 25

55% less capital invested

Capital invested by funds: $9.56M → $4.32M (-$5.24M)

63% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 19

Holders
54
Holders Change
-12
Holders Change %
-18.18%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
25
Closed
19
Calls
$351K
Puts
$89K
Net Calls
+$262K
Net Calls Change
+$272K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$162K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$157K
3
Simplex Trading
Simplex Trading
Illinois
+$154K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$147K
5
Bank of America
Bank of America
North Carolina
+$143K

Top Sellers

Rank Fund Capital Flow
1
SSA
Schonfeld Strategic Advisors
New York
-$1.12M
2
Morgan Stanley
Morgan Stanley
New York
-$735K
3
SPIA
Steward Partners Investment Advisory
New York
-$633K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$295K
5
Squarepoint
Squarepoint
New York
-$249K
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$14.1K -$24.6K -14,244 -52%
OC
27
Oppenheimer & Co
New York
$13.8K -$2.94K -1,700 -12%
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
$12.2K -$1.09K -629 -5%
Two Sigma Investments
29
Two Sigma Investments
New York
$12K +$19.6K +11,356 New
XT
30
XTX Topco
Cayman Islands
$11.7K -$125K -72,140 -87%
Osaic Holdings
31
Osaic Holdings
Arizona
$9.51K +$9.74K +5,633 +169%
PAS
32
Point72 Asia (Singapore)
Singapore
$6.16K -$7.65K -4,425 -43%
CSS
33
Cubist Systematic Strategies
Connecticut
$5.61K +$9.11K +5,269 +20,265%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$5K -$34.3K -19,819 -81%
Jones Financial Companies
35
Jones Financial Companies
Missouri
$2.42K +$4.32K +2,500 New
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$2.25K – – –
Wells Fargo
37
Wells Fargo
California
$1.5K -$304 -176 -11%
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.36K – – –
AA
39
Ancora Advisors
Ohio
$1.17K – – –
HI
40
Harbour Investments
Wisconsin
$870 – – –
Morgan Stanley
41
Morgan Stanley
New York
$821 -$735K -424,824 -100%
EWA
42
EverSource Wealth Advisors
Alabama
$738 -$218 -126 -15%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$323 -$429 -248 -45%
WANY
44
Wealthspire Advisors (New York)
New York
$318 +$519 +300 New
SS
45
SBI Securities
Japan
$223 – – –
AAG
46
Armstrong Advisory Group
Massachusetts
$190 – – –
Fidelity Investments
47
Fidelity Investments
Massachusetts
$112 -$295K -170,396 -100%
LFG
48
Larson Financial Group
Missouri
$106 – – –
TCM
49
Tradewinds Capital Management
Washington
$106 +$173 +100 New
PWMG
50
Prestige Wealth Management Group
New Jersey
$66 – – –
1
2
3

OTLK Hedge Fund Activity: Q3 2025 in Review

54 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Outlook Therapeutics (OTLK) for Q3 2025, worth a combined $4.32M — down 55% from $9.56M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of OTLK and 7 opened new positions — a net loss of 12 holders — while 25 trimmed existing stakes and 12 added.

The largest buyer was Susquehanna International Group, adding an estimated $162K. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $1.12M.

  • 54 institutional investors held Outlook Therapeutics (OTLK) as of Q3 2025, down from 66 in Q2 2025.
  • Funds reported $4.32M of Outlook Therapeutics stock for Q3 2025, down 55% quarter-over-quarter.
  • 7 funds opened new Outlook Therapeutics positions in Q3 2025 and 19 closed out, a net change of -12 holders.
  • The largest Outlook Therapeutics buyer in Q3 2025 was Susquehanna International Group, an estimated $162K added.
  • The largest Outlook Therapeutics seller in Q3 2025 was Schonfeld Strategic Advisors, an estimated $1.12M sold.

Based on aggregated 13F filings for Q3 2025.